New Information on Antivirals and Breastfeeding

Abstract

Get full access to this article

View all access options for this article.

References

Joseph Davey

, Nyemba

, Castillo-Mancilla

, et al. Adherence challenges with daily oral pre-exposure prophylaxis during pregnancy and the postpartum period in South African women: A cohort study. J Int AIDS Soc, 2022; 25:e26044; doi: 10.1002/jia2.26044

Wara

, Mvududu

, Marwa

, et al. Preferences and acceptability for long-acting PrEP agents among pregnant and postpartum women with experience using daily oral PrEP in South Africa and Kenya. medRxiv, 2022; doi: 10.1101/2022.10.29.22281701

Anderson

. COVID-19 drugs and breastfeeding update. Breastfeed Med, 2022; 17:377–379; doi: 10.1089/bfm.2022.0066

Chourasia

, Maringanti

, Edwards-Fligner

, et al. Paxlovid (nirmatrelvir and ritonavir) use in pregnant and lactating woman: Current evidence and practice guidelines-a scoping review. Vaccines (Basel), 2023; 11:107; doi: 10.3390/vaccines11010107